Enovix (NASDAQ:ENVX) Receives “Outperform” Rating from William Blair

William Blair restated their outperform rating on shares of Enovix (NASDAQ:ENVXFree Report) in a report released on Thursday morning, RTT News reports.

Several other research analysts have also recently weighed in on the company. JPMorgan Chase & Co. reduced their price target on Enovix from $18.00 to $12.00 and set an overweight rating for the company in a research report on Friday, April 26th. Cantor Fitzgerald reiterated an overweight rating and set a $30.00 price target on shares of Enovix in a research report on Thursday, April 25th. B. Riley reduced their price target on Enovix from $18.00 to $16.00 and set a buy rating for the company in a research report on Tuesday. Finally, Canaccord Genuity Group reiterated a buy rating and set a $17.00 price target on shares of Enovix in a research report on Wednesday, February 21st. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of Moderate Buy and a consensus price target of $25.29.

View Our Latest Stock Analysis on Enovix

Enovix Stock Performance

Shares of NASDAQ:ENVX traded up $0.62 during trading on Thursday, hitting $10.09. The stock had a trading volume of 11,963,656 shares, compared to its average volume of 5,634,649. Enovix has a 12-month low of $5.70 and a 12-month high of $23.90. The stock has a market capitalization of $1.71 billion, a price-to-earnings ratio of -7.53 and a beta of 1.70. The company has a quick ratio of 5.15, a current ratio of 5.30 and a debt-to-equity ratio of 0.65. The stock has a 50-day simple moving average of $7.88 and a two-hundred day simple moving average of $10.01.

Enovix (NASDAQ:ENVXGet Free Report) last announced its quarterly earnings data on Tuesday, February 20th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.01). Enovix had a negative return on equity of 83.66% and a negative net margin of 1,448.90%. The firm had revenue of $7.38 million during the quarter, compared to analysts’ expectations of $3.37 million. On average, equities research analysts expect that Enovix will post -1.13 earnings per share for the current fiscal year.

Insider Buying and Selling at Enovix

In other news, COO Ajay Marathe sold 4,954 shares of the stock in a transaction dated Sunday, April 14th. The stock was sold at an average price of $7.31, for a total value of $36,213.74. Following the transaction, the chief operating officer now owns 978,913 shares in the company, valued at approximately $7,155,854.03. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 17.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in ENVX. Electron Capital Partners LLC grew its stake in Enovix by 188.0% during the 3rd quarter. Electron Capital Partners LLC now owns 2,698,897 shares of the company’s stock worth $33,871,000 after buying an additional 1,761,834 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in Enovix by 2,228.5% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,438,011 shares of the company’s stock worth $11,518,000 after buying an additional 1,376,253 shares in the last quarter. Vanguard Group Inc. increased its position in Enovix by 9.5% during the third quarter. Vanguard Group Inc. now owns 12,415,485 shares of the company’s stock worth $155,814,000 after buying an additional 1,072,508 shares in the last quarter. Wellington Management Group LLP purchased a new position in Enovix during the third quarter worth $7,290,000. Finally, Sora Investors LLC purchased a new stake in shares of Enovix in the third quarter valued at $3,765,000. Hedge funds and other institutional investors own 50.92% of the company’s stock.

About Enovix

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Further Reading

Analyst Recommendations for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.